FDA Inspection 1038423 — Alan Breier, M.D.
The FDA completed an inspection of Alan Breier, M.D. on Dec 7, 2017 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 7, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Indianapolis, IN (United States)
Additional details
Clinical Investigator (CI)